INS and diabetes mellitus: Current efforts prioritize enhancing the efficacy and safety of exogenous insulin therapy, which remains the cornerstone of DM treatment, through the advanced insulin formulations and novel delivery systems (e.g., aerosolized and oral insulin); improving pancreatic/islet cell transplantation techniques; developing in vitro-derived β-cell alternatives.